Literature DB >> 9375914

Profound biotinidase deficiency in two asymptomatic adults.

B Wolf1, K Norrgard, R J Pomponio, D M Mock, J R McVoy, K Fleischhauer, S Shapiro, M G Blitzer, J Hymes.   

Abstract

Biotinidase deficiency is an autosomal-recessive disorder of biotin recycling. Children with profound biotinidase deficiency usually have neurological and cutaneous symptoms in early childhood, but they may not develop symptoms until adolescence. We now report on a man and a woman with profound biotinidase deficiency who are asymptomatic and who were diagnosed only because their biotinidase-deficient children were identified by newborn screening. These adults have never exhibited symptoms of the disorder and are homozygous for two different mutations resulting in different aberrant enzymes. There is no evidence of an increased dietary intake of biotin to explain why they have remained asymptomatic. Although these adults may still be at risk for developing symptoms, they could represent a small group of individuals with profound biotinidase deficiency who will never develop clinical problems. Their lack of symptoms suggests that there are probably epigenetic factors that protect some enzyme-deficient individuals from developing symptoms. These individuals broaden the spectrum of expression of biotinidase deficiency.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9375914     DOI: 10.1002/(sici)1096-8628(19971128)73:1<5::aid-ajmg2>3.0.co;2-u

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  13 in total

1.  Novel mutations cause biotinidase deficiency in Turkish children.

Authors:  R J Pomponio; T Coskun; M Demirkol; A Tokatli; I Ozalp; G Hüner; T Baykal; B Wolf
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

2.  Children with profound biotinidase deficiency should be treated with biotin regardless of their residual enzyme activity or genotype.

Authors:  Barry Wolf
Journal:  Eur J Pediatr       Date:  2002-03       Impact factor: 3.183

3.  Biotinidase deficiency--a treatable entity.

Authors:  S Gulati; G R Passi; A Kumar; M Kabra; V Kalra; I C Verma
Journal:  Indian J Pediatr       Date:  2000-06       Impact factor: 1.967

4.  Molecular characterisation and neuropsychological outcome of 21 patients with profound biotinidase deficiency detected by newborn screening and family studies.

Authors:  Dorothea Möslinger; Adolf Mühl; Terttu Suormala; Regula Baumgartner; Sylvia Stöckler-Ipsiroglu
Journal:  Eur J Pediatr       Date:  2003-11-20       Impact factor: 3.183

5.  Asymptomatic adults and older siblings with biotinidase deficiency ascertained by family studies of index cases.

Authors:  T Baykal; G Gokcay; Y Gokdemir; F Demir; Y Seckin; M Demirkol; K Jensen; B Wolf
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

6.  Adult-Onset Biotinidase Deficiency Induces Acutely Progressing Leukoencephalopathy.

Authors:  Goichi Beck; Daisuke Hirozawa; Keiichiro Honma; Kousuke Baba; Hisae Sumi; Eiichi Morii; Shigeo Murayama; Hideki Mochizuki
Journal:  Neurol Clin Pract       Date:  2021-06

7.  High incidence of profound biotinidase deficiency detected in newborn screening blood spots in the Somalian population in Minnesota.

Authors:  K Sarafoglou; K Bentler; A Gaviglio; K Redlinger-Grosse; C Anderson; M McCann; B Bloom; D Babovic-Vuksanovic; D Gavrilov; S A Berry
Journal:  J Inherit Metab Dis       Date:  2009-09-07       Impact factor: 4.982

8.  Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics.

Authors:  Erin T Strovel; Tina M Cowan; Anna I Scott; Barry Wolf
Journal:  Genet Med       Date:  2017-07-05       Impact factor: 8.822

9.  Biotinidase Deficiency: New Directions and Practical Concerns.

Authors:  Barry Wolf
Journal:  Curr Treat Options Neurol       Date:  2003-07       Impact factor: 3.972

10.  Genetic variation in an individual human exome.

Authors:  Pauline C Ng; Samuel Levy; Jiaqi Huang; Timothy B Stockwell; Brian P Walenz; Kelvin Li; Nelson Axelrod; Dana A Busam; Robert L Strausberg; J Craig Venter
Journal:  PLoS Genet       Date:  2008-08-15       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.